Cervical cancer screening method should be changed, research suggests

Apr 28, 2010

Cervical cancer screening intervals could be extended to five years for women aged 30 and over if the primary screening method was human papillomavirus (HPV) testing, say scientists at Queen Mary, University of London.

The research, published in the today (28 April), found HPV tests are very accurate in identifying early signs of , detecting more serious abnormalities compared to current cytology screening in women aged 30 and over.

Cervical cancer affects around 2,800 women each year in the UK, and it is one of the few cancers that can be prevented through early detection of pre-cancerous cells.

One of the study's authors, John Snow Professor of Epidemiology, Jack Cuzick, said: "Using HPV testing as the primary for cervical cancer would not only mean women could be screened less often but it would also mean efficiency savings for the NHS."

The study recruited more than 11,000 women from 161 family practices around the UK. Two samples were taken from each of the women; one using the conventional cytology screening method and the other was sent for HPV testing.

Results showed the women with HPV negative results had a lower rate of developing pre-cancerous (CIN2+) cells for at least six years compared with women who recorded a negative cytology result.

Lead author, David Mesher, from the Cancer Research UK Centre for Epidemiology, Mathematics and Statistics at Queen Mary, University of London, said: "The data shows HPV testing offers improved protection from CIN2+ after a negative result compared with the protection afforded from a normal cytology result."

Professor Cuzick added: "There is now an overwhelming case for moving to HPV as the primary screening test for women 30 and over and demonstration projects should start for this now."

* CIN stands for cervical intraepithelial neoplasia - a condition of the cervix, in which are present on the surface of the cervix. Over time, these cells may become cancerous. CIN is classified as 1, 2 or 3, depending on its severity.

Explore further: US OKs first-ever DNA alternative to Pap smear (Update 2)

More information: D. Mesher et al. "Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study", British Journal of Cancer (2010) 1-6.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

US OKs first-ever DNA alternative to Pap smear (Update 2)

13 hours ago

U.S. government health regulators have cleared a genetic test from Roche as a first-choice screening option for cervical cancer. It was a role previously reserved for the Pap smear, the decades-old mainstay of women's health.

New breast cancer imaging method promising

18 hours ago

The new PAMmography method for imaging breast cancer developed by the University of Twente's MIRA research institute and the Medisch Spectrum Twente hospital appears to be a promising new method that could ...

Palliation is rarely a topic in studies on advanced cancer

19 hours ago

End-of-life aspects, the corresponding terminology, and the relevance of palliation in advanced cancer are often not considered in publications on randomized controlled trials (RCTs). This is the result of an analysis by ...

User comments : 0

More news stories

Google+ boss leaving the company

The executive credited with bringing the Google+ social network to life is leaving the Internet colossus after playing a key role there for nearly eight years.